Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

3.86
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
1.97
Today|||52-Week Range
5.78
+78.80%
Year-to-Date
Company News For Dec 13, 2017
Dec 13 / Zacks.com - Paid Partner Content
2 Stocks Fall Tuesday
Dec 12 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close3.86
Today’s open4.00
Day’s range3.82 - 4.00
Volume324,779
Average volume (3 months)224,124
Market cap$174.5M
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)+55.10%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+28.97%
P/E ratioNM
Price/Sales2.77
Price/Book3.17

Competitors

 Today’s
change
Today’s
% change
VCELVericel Corp0.000.00%
MDWDMediwound Ltd0.000.00%
SRNESorrento Therapeutic...0.000.00%
TRVNTrevena Inc0.000.00%
Data as of 4:00pm ET, 12/15/2017

Financials

Last reporting dateDecember 11, 2017
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$57.6M
Annual profit (last year)-$28.2M
Net profit margin-48.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Financial Officer
Paul J. Lytle
Vice President-Clinical &
Regulatory Affairs
Joseph S. Shan
Corporate headquarters
Tustin, California

Forecasts